![Toru Yoshimitsu](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Toru Yoshimitsu
Directeur/Membre du Conseil chez
OCATA THERAPEUTICS INC
Profil
Toru Yoshimitsu is currently Director at Astellas Institute for Regenerative Medicine and Auditor at PHC Holdings Corp.
Former positions include Director at Astellas Pharma Europe Ltd. from 2017 to 2020 and Director at Astellas Gene Therapies, Inc.
Postes actifs de Toru Yoshimitsu
| Sociétés | Poste | Début |
|---|---|---|
| OCATA THERAPEUTICS INC | Directeur/Membre du Conseil | - |
| PHC HOLDINGS CORPORATION | Comptroller/Controller/Auditor | 01/06/2025 |
Anciens postes connus de Toru Yoshimitsu
| Sociétés | Poste | Fin |
|---|---|---|
Astellas Pharma Europe Ltd.
 Astellas Pharma Europe Ltd. Pharmaceuticals: MajorHealth Technology Develops and sells pharmaceutical products | Directeur/Membre du Conseil | 31/03/2020 |
| AUDENTES THERAPEUTICS, INC. | Directeur/Membre du Conseil | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
1
Relations au 1er degré
4
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Astellas Institute for Regenerative Medicine
 Astellas Institute for Regenerative Medicine Pharmaceuticals: MajorHealth Technology Engages in the development and commercialization of human pluripotent stem cell technology in the field of regenerative medicine | Health Technology |
Astellas Pharma Europe Ltd.
Astellas Pharma Europe Ltd. Pharmaceuticals: MajorHealth Technology Develops and sells pharmaceutical products | Health Technology |
Astellas Gene Therapies, Inc.
 Astellas Gene Therapies, Inc. BiotechnologyHealth Technology Develops and commercializes gene therapy products for patients with serious rare diseases | Health Technology |
PHC Holdings Corp.
 PHC Holdings Corp. Medical SpecialtiesHealth Technology Operates a holding company with interests in production and distribution of self-monitoring blood glucose systems | Health Technology |
